Products Investigational Tdap vaccine Formulation B + Investigational Tdap vaccine Formulation C + Investigational Tdap vaccine Formulation A + Investigational Tdap vaccine Formulation D + Licensed Tdap vaccine
Investigational Tdap vaccine Formulation B + Investigational Tdap vaccine Formulation C + Investigational Tdap vaccine Formulation A + Investigational Tdap vaccine Formulation D + Licensed Tdap vaccine Phase 1 Completed 💤 Quiet Tetanus Immunisation (Healthy Volunteers)
Tetanus Immunisation (Healthy Volunteers), Diphtheria Immunisation (Healthy Volunteers), Pertussis Immunisation (Healthy Volunteers)
Jun 26, 2019 → Apr 6, 2021
About Investigational Tdap vaccine Formulation B + Investigational Tdap vaccine Formulation C + Investigational Tdap vaccine Formulation A + Investigational Tdap vaccine Formulation D + Licensed Tdap vaccine Investigational Tdap vaccine Formulation B + Investigational Tdap vaccine Formulation C + Investigational Tdap vaccine Formulation A + Investigational Tdap vaccine Formulation D + Licensed Tdap vaccine is a phase 1 stage product being developed by Sanofi for Tetanus Immunisation (Healthy Volunteers). The current trial status is completed. This product is registered under clinical trial identifier NCT03958799. Target conditions include Tetanus Immunisation (Healthy Volunteers), Diphtheria Immunisation (Healthy Volunteers), Pertussis Immunisation (Healthy Volunteers).
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT03958799 Phase 1 Completed Jun 26, 2019 Apr 6, 2021 Tetanus Immunisation (Healthy Volunteers)
Competing Products 10 competing products in Tetanus Immunisation (Healthy Volunteers)
See all competitors Product Company Stage Hype Score Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®) + Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®) Sanofi Approved Tetanus-diphtheria-acellular pertussis (Tdap) vaccine Sanofi Approved Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus + Diphtheria and Tetanus Toxoids and Acellular Pertussis + Poliovirus + MMR + Varicella Virus + Diphtheria and Tetanus Toxoids and Acellular Pertussis + Measles, Mumps, Rubella + Varicella Virus + Diphtheria and Tetanus Toxoids and Acellular Pertussis + Poliovirus + MMR + Varicella Virus Sanofi Phase 3 Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed + Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Adsorbed Sanofi Approved DTaP-IPV/Hib Combined vaccine + DTaP-IPV vaccine and Hib vaccine + DTaP-IPV/Hib Combined vaccine Sanofi Phase 3 Tdap: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed + Diphtheria and Tetanus toxoids adsorbed Sanofi Phase 3 Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine + Tetanus and Diphtheria Toxoids Adsorbed For Adult Use Sanofi Approved Tdap (Tetanus Toxoid Reduced Diphtheria Toxoid/Acellular Pertussis) + DTaP (Diphtheria & Tetanus Toxoids & Acellular Pertussis Adsorbed) Sanofi Phase 3 Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1 + Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 2 + Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 3 + Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 4 + Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed + Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Sanofi Phase 1/2 Tetanus Immune Globulin (Human) + Diphtheria-Tetanus Toxoids Adsorbed Grifols Approved
Other Products from Sanofi